ONGOING CLINICAL TRIAL: A PROSPECTIVE MULTICENTRE, PHASE 2B RANDOMISED, CONTROLLED DOUBLE-BLIND TRIAL TO DETERMINE THE SAFETY AND EFFICACY OF PERISPINAL ETANERCEPT ON QUALITY OF LIFE

被引：0

作者：

Thijs, V. ^{[1
]}

Bernhardt, J. ^{[1
]}

Cloud, G. ^{[2
]}

Churilov, L. ^{[3
]}

Sprigg, N. ^{[4
]}

Parsons, B. ^{[1
]}

Gilchrist, N. ^{[5
,6
]}

Walker, M. ^{[6
,7
]}

Bath, P. ^{[7
]}

机构：

[1] Florey Inst Neurosci & Mental Hlth, Stroke Theme, Heidelberg, Vic, Australia

[2] Alfred Hlth, Stroke, Melbourne, Vic, Australia

[3] Univ Melbourne, Melbourne Med Sch, Melbourne, Vic, Australia

[4] Univ Nottingham, Sch Med, Stroke Trials Unit, Nottingham, England

[5] CGM Res Trust, Cgm, Christchurch, New Zealand

[6] Univ Nottingham UK, Div Rehabil Ageing & Wellbeing, Nottingham, England

[7] Nottingham Univ Hosp NHS Trust, Stroke, Dept Med, Nottingham, England

来源：

INTERNATIONAL JOURNAL OF STROKE | 2021年 / 16卷 / 2_SUPPL期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

WSC21-222

引用

页码：27 / 27

页数：1

共 50 条

[41] Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Mercuri, Eugenio
Vilchez, Juan J.
Boespflug-Tanguy, Odile
Zaidman, Craig M.
Mah, Jean K.
Goemans, Nathalie
Mueller-Felber, Wolfgang
Niks, Erik H.
Schara-Schmidt, Ulrike
Bertini, Enrico
Comi, Giacomo P.
Mathews, Katherine
Servais, Laurent
Vandenborne, Krista
Johannsen, Jessika
Messina, Sonia
Spinty, Stefan
Mcadam, Laura
Selby, Kathryn
Byrne, Barry
Laverty, Chamindra G.
Carroll, Kevin
Zardi, Giulia
Cazzaniga, Sara
Coceani, Nicoletta
Bettica, Paolo
Mcdonald, Craig M.
LANCET NEUROLOGY, 2024, 23 (04): : 393 - 403
[42] The Bexagliflozin Efficacy and Safety Trial (BEST): A Randomized, Double-Blind, Placebo-Controlled, Phase IIII, Clinical Trial
McMurray, John J. V.
Freeman, Mason W.
Massaro, Joe
Solomon, Scott
Lock, Paul
Riddle, Matthew C.
Halvorsen, Yuan-Di C.
DIABETES, 2020, 69
[43] Efficacy and safety of linaclotide in treating functional constipation in paediatric patients: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
Di Lorenzo, Carlo
Khlevner, Julie
Rodriguez-Araujo, Gerardo
Xie, Wangang
Huh, Susanna Y.
Ando, Masakazu
Hyams, Jeffrey S.
Nurko, Samuel
Benninga, Marc A.
Simon, Michael
Hewson, Marcella E.
Saps, Miguel
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2024, 9 (03): : 238 - 250
[44] Pirfenidone in fibrotic hypersensitivity pneumonitis: a double-blind, randomised clinical trial of efficacy and safety
Keshvari, Amir
Mollamohammadi, Leila
Keramati, Mohammad Reza
Behboudi, Behnam
Fazeli, Mohammad Sadegh
Kazemeini, Alireza
Naseri, Amirhossein
Shahmohammadi, Elnaz
Foroutani, Laleh
Ayati, Aryan
Tayebi, Amirhossein
Sajjadian, Zahra
Hadizadeh, Alireza
Ahmadi-Tafti, Seyed-Mohsen
UPDATES IN SURGERY, 2023, 75 (04) : 847 - 854
[45] Pirfenidone in fibrotic hypersensitivity pneumonitis: a double-blind, randomised clinical trial of efficacy and safety
Perez, Evans R. Fernandez
Crooks, James L.
Lynch, David A.
Humphries, Stephen M.
Koelsch, Tilman L.
Swigris, Jeffrey J.
Solomon, Joshua J.
Mohning, Michael P.
Groshong, Steve D.
Fier, Kaitlin
THORAX, 2023, 78 (11) : 1097 - 1104
[46] Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial
Maio, Michele
Scherpereel, Arnaud
Calabro, Luana
Aerts, Joachim
Cedres Perez, Susana
Bearz, Alessandra
Nackaerts, Kristiaan
Fennell, Dean A.
Kowalski, Dariusz
Tsao, Anne S.
Taylor, Paul
Grosso, Federica
Antonia, Scott J.
Nowak, Anna K.
Taboada, Maria
Puglisi, Martina
Stockman, Paul K.
Kindler, Hedy L.
LANCET ONCOLOGY, 2017, 18 (09): : 1261 - 1273
[47] Efficacy and safety of Obex® in overweight and obese subjects: a randomised, double-blind, placebo-controlled clinical trial
Eduardo Cabrera-Rode
Ileana Cubas-Dueñas
Janet Rodríguez Acosta
Jeddú Cruz Hernández
Ana Ibis Conesa González
Teresa M. González Calero
Yuri Arnold Domínguez
José Hernández Rodríguez
Antonio D. Reyes Rodríguez
Aimee Álvarez Álvarez
Ragmila Echevarría Valdés
Liudmila Jorge Espinosa
Onelia Torres Belent
Zoila Bell Benavides
Elizabeth Senra Estévez
Yanet Abreu Rodríguez
Juana del Valle Rodríguez
Silvia Marín Juliá
BMC Complementary Medicine and Therapies, 23
[48] Efficacy and safety of Obex® in overweight and obese subjects: a randomised, double-blind, placebo-controlled clinical trial
Cabrera-Rode, Eduardo
Cubas-Duenas, Ileana
Rodriguez Acosta, Janet
Cruz Hernandez, Jeddu
Conesa Gonzalez, Ana Ibis
Gonzalez Calero, Teresa M.
Arnold Dominguez, Yuri
Hernandez Rodriguez, Jose
Reyes Rodriguez, Antonio D.
Alvarez Alvarez, Aimee
Echevarria Valdes, Ragmila
Jorge Espinosa, Liudmila
Torres Belent, Onelia
Bell Benavides, Zoila
Senra Estevez, Elizabeth
Abreu Rodriguez, Yanet
del Valle Rodriguez, Juana
Marin Julia, Silvia
BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2023, 23 (01)
[49] Quality of Life in patients with Marfan syndrome included in a randomised controlled double-blind trial
De Nobele, S.
Loeys, B.
De Paepe, A.
De Backer, J.
EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2011, 10 : S17 - S17
[50] Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial
Riva, Nilo
Mora, Gabriele
Soraru, Gianni
Lunetta, Christian
Ferraro, Ottavia E.
Falzone, Yuri
Leocani, Letizia
Fazio, Raffaella
Comola, Mauro
Comi, Giancarlo
Formaglio, Fabio
Rossi, Paolo
Clerici, Marta
Falzone, Yuri Matteo
Pozzi, Laura
Martinelli, Daniele
Cerri, Federica
Diego, Lopez Ignazio
Martinelli-Boneschi, Filippo
Quattrini, Angelo
Pieri, Elisabetta
Marinou, Kalliopi
Querin, Giorgia
Sansone, Valeria
Maestri, Eleonora
Calvo, Andrea
Chio, Adriano
LANCET NEUROLOGY, 2019, 18 (02): : 155 - 164

← 1 2 3 4 5 →